Day: February 5, 2021

Clean Power Increases Its Investment in PowerTap to 94.5%

VANCOUVER, British Columbia, Feb. 05, 2021 (GLOBE NEWSWIRE) — Clean Power Capital Corp. (CSE: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Power” or the “Company” or “MOVE”) is pleased to announce that it has increased its investment in PowerTap Hydrogen Fueling Corp. (“PowerTap”) by acquiring an additional 4.5% equity interest in PowerTap. As previously announced, the Company initially invested in PowerTap on October 27, 2020 by acquiring a 90% equity interest. With the latest investment, Clean Power has increased its equity interest in PowerTap to 94.5%.PowerTap is leading the charge to build out cost-effective hydrogen fueling infrastructure through its environmentally friendly intellectual property, product design for the modularized and lowest tier production cost of hydrogen and launch plan. PowerTap technology-based...

Continue reading

Bragg Gaming Group Interview to Air on Bloomberg International

TORONTO, Feb. 05, 2021 (GLOBE NEWSWIRE) — Bragg Gaming Group (TSX: BRAG, OTC: BRGGF) (“Bragg” or the “Company”), today announced an interview with Chief Strategy Officer Yaniv Spielberg will air on Bloomberg International on Sunday, February 7, at 6 p.m. local time across Europe in 100M homes. The segment will also air on Bloomberg Television U.S. on Saturdays at 7 p.m. local time in 73M homes.In the exclusive interview, Spielberg discusses Bragg Gaming Group’s emergence as a leader in the evolving global gaming industry. He also discusses the Company’s turnkey solutions for online gambling operators, as well as how the company plans to scale business and revenues.To view the interview segment, please visit: https://youtu.be/WkTqD-9vC-sAbout Bragg Gaming GroupBragg Gaming Group (TSX: BRAG, OTC: BRGGF) is...

Continue reading

VivoPower International PLC Confirms Date for Half Year Results and Earnings Conference Call

LONDON, Feb. 05, 2021 (GLOBE NEWSWIRE) — VivoPower International PLC (Nasdaq: VVPR) (“VivoPower”) is pleased to confirm that it will announce results for the half year ended December 31, 2020, on Wednesday, February 24, 2021 at 16:00 EST / 21:00 BST.The Company also confirmed that Kevin Chin, Executive Chairman and CEO, will host an earnings conference call on Wednesday, February 24, 2021 at 16:30 EST / 21:30 BST, alongside other key leaders of VivoPower.The dial-in phone number for the live audio call are:Conference ID: 3460277Date of call: 02/24/2021Leader Toll-Free Dial-In Number: (833) 398-0998Leader International Dial-In Number: (914) 987-7709Participant Toll-Free Dial-In Number: (833) 362-0227Participant International Dial-In Number:(914) 987-7684A live webcast of the conference call will be available at https://edge.media-server.com/mmc/p/bcmv8et2...

Continue reading

Allied Announces Pricing of $600 Million Green Bond Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES OF AMERICATORONTO, Feb. 05, 2021 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (TSX:AP.UN) (“Allied”) announced today that it has priced its previously announced offering, and has agreed to issue $600 million aggregate principal amount of series H senior unsecured debentures (the “Debentures”). The Debentures will bear interest at a rate of 1.726% per annum and will mature on February 12, 2026. The Debentures are being offered on an agency basis by a syndicate of agents led by Scotia Capital Inc., BMO Nesbitt Burns Inc. and CIBC World Markets Inc. The offering is expected to close on or about February 12, 2021. DBRS Limited has provided Allied with a provisional credit rating of “BBB” with a “Stable” trend relating to the...

Continue reading

Bespoke Capital Acquisition Corp. Announces Listing on Nasdaq

Bespoke Capital Acquisition Corp. to begin trading on the Nasdaq on February 8, 2021 under the symbol BSPETORONTO, Feb. 05, 2021 (GLOBE NEWSWIRE) — Bespoke Capital Acquisition Corp. (NASDAQ: BSPE) (TSX: BC.U) (TSX: BC.WT.U) (OTCPK:BKCQ.F) (“Bespoke” or “BCAC”), a publicly-traded special purpose acquisition company, announced today that its Class A Restricted Voting shares were approved for listing on the Nasdaq Global Market, and will begin trading on the Nasdaq on Monday, February 8, 2021 under the symbol “BSPE”. Bespoke’s Warrants will continue to trade OTC in the U.S. Bespoke’s Class A Shares and warrants will remain listed on the Toronto Stock Exchange under its current symbols.On February 4, 2021, BCAC announced a definitive agreement for a business combination with Vintage Wine Estates (“VWE” or the “Company”), one of the fastest...

Continue reading

AIM ImmunoTech完成并结束了ATM工具;当前资金有望满足当前临床试验的需求

佛罗里达州奥卡拉, Feb. 06, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc.(纽约证券交易所股票代码:AIM)今天宣布已经完成了其市价(ATM)工具,并结束了ATM的股票发行协议(EDA)。管理层相信,根据公司当前的财务状况,公司有足够的资金来满足其预期的运营现金需求,并在未来大约二十四个月内都为当前的临床试验提供资金。“我们稳健的财务状况应使我们能够朝着许多重要目标迈进,因为我们朝着前面提到的许多重要拐点前进,无需续展基于EDA的ATM工具。尽管我们在基于政府、非政府组织(NGO)或行业资助发起研究者申办的临床试验方面有着出色往绩,但我们现在希望加快AIM申办的肿瘤、新冠肺炎、ME/CFS和新冠长期症状的发展计划。”AIM首席执行官Thomas K. Equels表示, “我相信,迄今为止我们在肿瘤学、ME/CFS、新冠肺炎和新冠长期症状方面的清晰进展已经预示了2021年将要发生的事情。我们在AIM的团队将努力实现实质性的进步,以实现我们明确的目标。”关于AIM ImmunoTech Inc.AIM ImmunoTech Inc.是一家免疫药物公司,致力于研究和开发治疗多种类型癌症、免疫疾病和病毒性疾病(包括由SARS-CoV-2病毒引起的新冠肺炎)的方法。警示声明本新闻稿载有1995年《私人证券诉讼改革法案》(PSLRA)所定义的“前瞻性声明”。诸如“可能”、“将会”、“预期”、“计划”、“预计”等词语和类似表达(以及提及未来事件或情况的其他词语或表达)旨在标示前瞻性声明。这些前瞻性声明中有许多涉及多项风险和不确定性。其中,公司主张对上述声明给予PSLRA中包含的前瞻性声明安全港保护。公司预计的财务和运营需求基于各种假设,包括但不限于当前研究的积极结果,且此类结果无需对此类研究或其他研究进行额外的意外更改。如果发生其中部分或多个意外事件,公司很可能需要额外的资金。鉴于新冠肺炎紧急医疗情况,临床试验招募和报告可能会出现延误。我们不承诺对该等前瞻性陈述进行更新以反映本协议日期之后发生的事件或情况。联系方式:Crescendo...

Continue reading

AIM ImmunoTech、進行中の臨床試験ニーズに対応する資金を確保済みとして、ATMファシリティを完了、クローズ

フロリダ州オカラ発, Feb. 06, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) は本日、アットザマーケット (ATM) ファシリティを完了し、ATMエクイティ・ディストリビューション契約 (EDA) をクローズしたことを発表した。経営陣は、同社の現在の財務状況は予想される運転資金ニーズを満たしており、今後約24か月間、進行中の臨床試験に資金を提供するのに十分な資金が確保されていると確信している。AIMのCEOであるトーマス・K・エクルズ (Thomas K. Equels) は次のように述べている。「先に述べた数々の重要な転換点に向けて前進する中、現在の健全な財務状態を踏まえれば、EDAベースのATMファシリティを更新しなくても、目標に向けて多くの重要な成果を達成することができるでしょう。当社には、政府機関、非政府機関 (NGO)、または業界の補助金を受けた研究者主導臨床試験の開始で、優れた実績がありますが、今後はがん、新型コロナウイルス感染症、ME/CFS、新型コロナ後遺症の分野において、迅速な行動が求められる状況で独自に資金調達活動をして、AIM資金による開発プログラムを加速していきたいと思っています。がん、ME/CFS、新型コロナウイルス感染症、新型コロナ後遺症の分野では、現在までに目に見える進歩を遂げているため、2021年に何らかの成果が期待できると考えています。AIM担当チームは、明示された目標達成に向けて重要な前進を遂げるべく、懸命に取り組んでいきます。」AIM ImmunoTechについてAIM ImmunoTech Inc.は、複数のタイプのがんや免疫障害、ウイルス性疾患 (SARS-CoV-2ウイルスが原因で発症する新型コロナウイルス感染症を含む) の治療法の研究開発に注力する免疫製薬会社である。注意事項本プレスリリースには、1995年米国証券民事訴訟改革法...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.